Home » Newsletters » The Carlat Hospital Psychiatry Report

The Carlat Hospital Psychiatry Report

Metabolic Side Effects (July/August/September) | 2021

View Archived Issues

CME Post-Test - Metabolic Side Effects, CHPR, July/August/September 2021

The post-test for this issue is available for one year after the publication date to subscribers. By successfully completing the test you will be awarded a certificate for 2 CME credits. Read More

Battle of the Bulge: Obesity and Antipsychotic-Induced Weight Gain

With so many weight loss medications on the market, it’s hard to know which to choose. Dr. Khorassani tells us everything we need to know to about selecting and prescribing these agents. Also, she gives us additional tips for managing antipsychotic-induced weight gain. Read More

Weight Gain and Metabolic Side Effects

Dr. Steve Marder describes interventions to minimize patients’ antipsychotic-induced weight gain and insulin resistance. Read More

Sex-Based Treatment of Schizophrenia

We can use our knowledge of gender differences in schizophrenia, argues Dr. Kulkarni, to inform and broaden our interventions for female patients. Read More

New Combination Treatment Mitigates Antipsychotic-Induced Weight Gain

When olanzapine is combined with an opioid-antagonist, patients gain less weight. Read More

Anti-NMDA Receptor Encephalitis or New-Onset Psychosis?

A type of autoimmune encephalitis causes agitation and psychosis, especially in young women. Read More

Psilocybin: The New Holy Grail for the Rapid Relief of Major Depression?

Like ketamine, psilocybin works quickly to relieve depression, but it’s not habit-forming and its effects might last longer. Read More

Learning Objectives, Metabolic Side Effects, CHPR, July/August/September 2021

After reading these articles, you should be able to… Read More

(PRE-ORDER) Treating Alcohol Use Disorder—A Fact Book (2023)
All the tools and information needed to assess and treat your patients who are struggling with...
READ MORE

General Psychiatry
Using SAMe In Clinical Practice with Garrett Rossi, MD
Read More

Hospital Psychiatry
Management of Depression and Neurocognitive Impairment in Patients With HIV
Strategies for the evaluation and management of HIV-associated mood and cognitive changes and potential drug interactions between psychiatric and antiretroviral medications.
Listen now

Approaches to Autism Intervention
January 31, 2022
Currently Available Cannabis Products
September 1, 2022
Interpreting Assessment Discrepancies from Multiple Sources
October 17, 2022

Approaches to Autism Intervention
January 31, 2022
Currently Available Cannabis Products
September 1, 2022
Interpreting Assessment Discrepancies from Multiple Sources
October 17, 2022

Approaches to Autism Intervention
January 31, 2022
Currently Available Cannabis Products
September 1, 2022
Interpreting Assessment Discrepancies from Multiple Sources
October 17, 2022